The strain is believed to account for 8.2% of recent cases, and the World Health Organization (WHO) has classified it as a “variant under monitoring” due to its high transmissibility and immune evasion capabilities.
Related Posts
Health insurance renewals in country touch all-time high persistency in FY26: Report
Post Views: 24 The report highlighted that the surge in…
Superbugs now resistant to key everyday antibiotics: ICMR
Post Views: 6 ICMR’s annual report 2024 ‘Antimicrobial Resistance Research…
Sun Pharma launches Leqselvi in the US
Post Views: 44 Sun Pharma has launched Leqselvi (deuruxolitinib, 8 mg)…
